Zusammenfassung
Komplikationen bei der Behandlung eines Typ-1-Diabetes entstehen durch zu viel oder zu wenig Insulin im Blut. Wird relativ zur körperlichen Bewegung und der Kohlenhydratzufuhr zu viel Insulin gespritzt, dann entstehen Unterzuckerungen. Wurde abhängig vom Bedarf längerfristig zu wenig oder gar kein Insulin injiziert, dann droht eine ketoazidotische Entgleisung.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
American Diabetes Association (2018) Glycemic targets: standards of medical care in diabetes-2018. Diabetes Care 41:S55–S65
Arbelaez AM et al (2013) Glycemic extremes in youth with T1DM: effects on the developing brain’s structural and functional integrity. Pediatr Diabetes 14:541–553
Bergenstal RM, ASPIRE In-Home Study Group et al (2013) Threshold-based insulin-pump interruption for reduction of hypoglycemia. New Engl J Med 369:224–232
Beschluss des Gemeinsamen Bundesausschusses über eine Änderung der Richtlinie Methoden vertragsärztliche Versorgung: Kontinuierliche interstitielle Glukosemessung mit Real-Time-Messgeräten (rtCGM) zur Therapiesteuerung bei Patientinnen und Patienten mit insulinpflichtigem Diabetes mellitus (2016) www.g-ba.de
Cengiz D et al (2013) Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes 14:447–454
Cryer PE (1992) Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes 41:255–260
DCCT-Studie, Jacobson AM et al (2007) Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356(18):1842–1852
Edridge CL et al (2015) Prevalence and incidence of hypoglycemia in 523,543 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies. PLoS One 10:e0126427
Ferguson SC et al (2005) Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 28(6):1431–1437
Holterhus PM et al (2016) Leitlinie von diabtesDE und AGPD Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. www.diabetesDE.org
Hsu P-F et al (2013) Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes. Diabetes Care 36:894–900
Jauch-Chara K et al (2007) Awakening and counterregulatory response to hypoglycemia during early and late sleep. Diabetes 56(7):1938–1942
Karges B et al (2014) Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,359 patients between 1995 and 2012. PLoS Med 11(10):e1001742
Laffel L et al (2012) Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the pre-randomization run-in phase of the TODAY study. Pediatr Diabetes 13:385–391
Mitrakou A et al (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Phys 260(1 Pt 1):E67–E74
Pacaud et al (2018) Risk of recurrent severe hypoglycemia remains associated with a past history of severe hypoglycemia up to 4 years: results from a large prospective contemporary pediatric cohort of the DPV initiative. Pediatr Diabetes 19(3):493–500
Perantie DC et al (2011) Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes 60:3006–3014
Peters A et al (2004) The selfish brain: competition for energy resources. Neurosci Biobehav Rev 28:143–180
Rickels MR et al (2016) Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes. Diabetes Care 39:264–270
Rosenbauer J et al (2012) Improved metabolic control in children and adolescents with type 1 diabetes. Diabetes Care 35:80–86
Rovet JF et al (1999) The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. J Pediatr 134(4):503–506
Schwab KO et al (1997) Symptoms of hypoglycaemia in children and adolescents with type 1 diabetes mellitus. Mschr Kinderheilkd 145:120–127
Schwab KO et al (2004) Hypoglycemia-dependent beta2-adrenoceptor downregulation: a contributing factor to hypoglycemia unawareness in patients with type-1 diabetes? Horm Res 62(3):137–141
Schwartz NS et al (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79(3):777–781
Stenninger E et al (1993) Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:931–935
Zisser H et al (2014) Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. Diabetes Technol Ther 16:613–622
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Schwab, K.O., Doerfer, J. (2020). Hypoglykämie bei Kindern und Jugendlichen. In: Hiort, O., Danne, T., Wabitsch, M. (eds) Pädiatrische Endokrinologie und Diabetologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57309-9_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-57309-9_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57308-2
Online ISBN: 978-3-662-57309-9
eBook Packages: Medicine (German Language)